GSK plc

GSKleader

GSK is a global biopharma company focused on infectious diseases, HIV, respiratory, and immunology, with the world's leading shingles vaccine Shingrix and majority-owned ViiV Healthcare.

⇄ Compare

Produk & Pendapatan

Pangsa Pendapatan Produk

Komposisi Pendapatan ($37.5B)

Data statis (memuat keuangan langsung…)

Commercial (Specialty) (50%)

Vaccines (28%)

General Medicines (22%)

Komposisi segmen dan pelanggan utama

Detail produk

HIV (ViiV Healthcare)28%

Dolutegravir-based regimens — world's most prescribed HIV treatments

Shingrix & Vaccines25%

#1 shingles vaccine and broad vaccine portfolio

Respiratory22%

Trelegy Ellipta and Nucala for asthma/COPD

Oncology & Other25%

Zejula (PARP inhibitor) and general medicines

Hubungan Rantai Pasok

Pesaing

Pfizer Inc.

Vaccines and respiratory

Dampak: High — overlapping vaccine portfolios

Sanofi

Vaccines

Dampak: Medium — vaccine market competition

Merck & Co.

Vaccines (Gardasil vs Shingrix market)

Dampak: Medium — different vaccine segments

Konteks makro dan pasar

제약 / 바이오Berita sektor

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

Katalis mendatang

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

Berita terkini

Memuat berita...

Analisis AI

Klik "Dapatkan Analisis AI" untuk analisis rantai pasok GSK plc.

Info Perusahaan

Kantor Pusat

London, United Kingdom

Didirikan

2000

Karyawan

70,000+

Situs Web

gsk.com

Gambaran umum sektor — 제약 / 바이오

Berita sektor